Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385665623> ?p ?o ?g. }
- W4385665623 endingPage "2101" @default.
- W4385665623 startingPage "2101" @default.
- W4385665623 abstract "Type 2 diabetes is a metabolic disorder that leads to accelerated skeletal muscle atrophy. In this study, we aimed to evaluate the effect of salbutamol (SLB) on skeletal muscle atrophy in high-fat diet (HFD)/streptozotocin (STZ)-induced diabetic rats. Male Sprague Dawley rats were divided into four groups (n = 6): control, SLB, HFD/STZ, and HFD/STZ + SLB (6 mg/kg orally for four weeks). After the last dose of SLB, rats were assessed for muscle grip strength and muscle coordination (wire-hanging, rotarod, footprint, and actophotometer tests). Body composition was analyzed in live rats. After that, animals were sacrificed, and serum and gastrocnemius (GN) muscles were collected. Endpoints include myofibrillar protein content, muscle oxidative stress and antioxidants, serum pro-inflammatory cytokines (interleukin-1β, interleukin-2, and interleukin-6), serum muscle markers (myostatin, creatine kinase, and testosterone), histopathology, and muscle 1H NMR metabolomics. Findings showed that SLB treatment significantly improved muscle strength and muscle coordination, as well as increased lean muscle mass in diabetic rats. Increased pro-inflammatory cytokines and muscle markers (myostatin, creatine kinase) indicate muscle deterioration in diabetic rats, while SLB intervention restored the same. Also, Feret’s diameter and cross-sectional area of GN muscle were increased by SLB treatment, indicating the amelioration in diabetic rat muscle. Results of muscle metabolomics exhibit that SLB treatment resulted in the restoration of perturbed metabolites, including histidine-to-tyrosine, phenylalanine-to-tyrosine, and glutamate-to-glutamine ratios and succinate, sarcosine, and 3-hydroxybutyrate (3HB) in diabetic rats. These metabolites showed a pertinent role in muscle inflammation and oxidative stress in diabetic rats. In conclusion, findings showed that salbutamol could be explored as an intervention in diabetic-associated skeletal muscle atrophy." @default.
- W4385665623 created "2023-08-09" @default.
- W4385665623 creator A5015745621 @default.
- W4385665623 creator A5016212346 @default.
- W4385665623 creator A5031357270 @default.
- W4385665623 creator A5037894792 @default.
- W4385665623 creator A5045695329 @default.
- W4385665623 creator A5054475634 @default.
- W4385665623 creator A5071694143 @default.
- W4385665623 creator A5073357921 @default.
- W4385665623 creator A5085887595 @default.
- W4385665623 date "2023-08-08" @default.
- W4385665623 modified "2023-09-30" @default.
- W4385665623 title "Salbutamol Attenuates Diabetic Skeletal Muscle Atrophy by Reducing Oxidative Stress, Myostatin/GDF-8, and Pro-Inflammatory Cytokines in Rats" @default.
- W4385665623 cites W1482756659 @default.
- W4385665623 cites W1504733522 @default.
- W4385665623 cites W1535680104 @default.
- W4385665623 cites W1835869439 @default.
- W4385665623 cites W18381781 @default.
- W4385665623 cites W1936637179 @default.
- W4385665623 cites W1972716867 @default.
- W4385665623 cites W1978670002 @default.
- W4385665623 cites W1982798204 @default.
- W4385665623 cites W1983310681 @default.
- W4385665623 cites W1983885111 @default.
- W4385665623 cites W1992900987 @default.
- W4385665623 cites W1994725808 @default.
- W4385665623 cites W1995199032 @default.
- W4385665623 cites W2016125879 @default.
- W4385665623 cites W2020896810 @default.
- W4385665623 cites W2039762060 @default.
- W4385665623 cites W2043347491 @default.
- W4385665623 cites W2044076811 @default.
- W4385665623 cites W2051366884 @default.
- W4385665623 cites W2051825204 @default.
- W4385665623 cites W2052290318 @default.
- W4385665623 cites W2053079324 @default.
- W4385665623 cites W2059814101 @default.
- W4385665623 cites W2063028213 @default.
- W4385665623 cites W2068256216 @default.
- W4385665623 cites W2087313135 @default.
- W4385665623 cites W2087892763 @default.
- W4385665623 cites W2096247672 @default.
- W4385665623 cites W2102615617 @default.
- W4385665623 cites W2105086882 @default.
- W4385665623 cites W2105216337 @default.
- W4385665623 cites W2109874388 @default.
- W4385665623 cites W2111648449 @default.
- W4385665623 cites W2116945158 @default.
- W4385665623 cites W2117457995 @default.
- W4385665623 cites W2123384926 @default.
- W4385665623 cites W2165211507 @default.
- W4385665623 cites W2165474199 @default.
- W4385665623 cites W2335532089 @default.
- W4385665623 cites W2405622496 @default.
- W4385665623 cites W2409181047 @default.
- W4385665623 cites W2412531331 @default.
- W4385665623 cites W2460513225 @default.
- W4385665623 cites W2520222164 @default.
- W4385665623 cites W2531766156 @default.
- W4385665623 cites W2550219701 @default.
- W4385665623 cites W2747708914 @default.
- W4385665623 cites W2767878254 @default.
- W4385665623 cites W2787075797 @default.
- W4385665623 cites W2791011305 @default.
- W4385665623 cites W2809821989 @default.
- W4385665623 cites W2897144948 @default.
- W4385665623 cites W2929263901 @default.
- W4385665623 cites W2939034184 @default.
- W4385665623 cites W2946336271 @default.
- W4385665623 cites W2948851550 @default.
- W4385665623 cites W2963941845 @default.
- W4385665623 cites W2981588241 @default.
- W4385665623 cites W2995498671 @default.
- W4385665623 cites W3009739189 @default.
- W4385665623 cites W3012251725 @default.
- W4385665623 cites W3033924432 @default.
- W4385665623 cites W3048573446 @default.
- W4385665623 cites W3093673763 @default.
- W4385665623 cites W3097710518 @default.
- W4385665623 cites W3113942155 @default.
- W4385665623 cites W3123549580 @default.
- W4385665623 cites W3134021199 @default.
- W4385665623 cites W3138014196 @default.
- W4385665623 cites W3158791987 @default.
- W4385665623 cites W3214719511 @default.
- W4385665623 cites W4206106053 @default.
- W4385665623 cites W4210300668 @default.
- W4385665623 cites W4214705321 @default.
- W4385665623 cites W4226071500 @default.
- W4385665623 cites W4285741545 @default.
- W4385665623 cites W4291014949 @default.
- W4385665623 doi "https://doi.org/10.3390/pharmaceutics15082101" @default.
- W4385665623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37631314" @default.
- W4385665623 hasPublicationYear "2023" @default.
- W4385665623 type Work @default.
- W4385665623 citedByCount "0" @default.
- W4385665623 crossrefType "journal-article" @default.